Correction: Abcg2a is the functional homolog of human ABCG2 expressed at the zebrafish blood–brain barrier

Correction: Abcg2a is the functional homolog of human ABCG2 expressed at the zebrafish blood–brain barrier

Saved in:

Bibliographic Details
Main Authors:	Joanna R. Thomas, William J. E. Frye, Robert W. Robey, Andrew C. Warner, Donna Butcher, Jennifer L. Matta, Tamara C. Morgan, Elijah F. Edmondson, Paula B. Salazar, Suresh V. Ambudkar, Michael M. Gottesman
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Series:	Fluids and Barriers of the CNS
Online Access:	https://doi.org/10.1186/s12987-024-00606-9
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ABCG1 and ABCG4 Suppress γ-Secretase Activity and Amyloid β Production.
by: Osamu Sano, et al.
Published: (2016-01-01)

Dimerization of ABCG2 analysed by bimolecular fluorescence complementation.
by: Ameena J Haider, et al.
Published: (2011-01-01)

Association of <i>ABCG5</i> and <i>ABCG8</i> Polymorphisms with Gallstone Disease and Gallbladder Cancer
by: I. N. Grigor’eva, et al.
Published: (2025-06-01)

Reversal of ABCG2-mediated drug resistance by tinodasertib (ETC-206)
by: Haigan Yang, et al.
Published: (2025-06-01)

Correction: Reversal of ABCG2-mediated drug resistance by tinodasertib (ETC-206)
by: Haigan Yang, et al.
Published: (2025-08-01)

The human ABCG2 transporter engages three gates to control multidrug extrusion
by: Narakorn Khunweeraphong, et al.
Published: (2025-03-01)

The suberin transporter StABCG1 is required for barrier formation in potato leaves
by: Elvio Henrique Benatto Perino, et al.
Published: (2025-03-01)

Analysis of ABCG2 gene rs2231142 single nucleotide polymorphism and risk factors in hyperuricemia
by: Meiting Liang, et al.
Published: (2025-03-01)

First verification of human small intestinal uric acid secretion and effect of ABCG2 polymorphisms
by: Ryosuke Miyazaki, et al.
Published: (2025-03-01)

ML210 Antagonizes ABCB1- Not ABCG2-Mediated Multidrug Resistance in Colorectal Cancer
by: Yan-Chi Li, et al.
Published: (2025-05-01)

Expression of Potential Cancer Stem Cell Marker ABCG2 is Associated with Malignant Behaviors of Hepatocellular Carcinoma
by: Guang Zhang, et al.
Published: (2013-01-01)

Outcomes Associated With ABCG2 and CD133 Expression in Patients With Gastric Cancer After Surgical Resection
by: Donghoon Kang, et al.
Published: (2023-12-01)

Unraveling the role of GOLM1-OPN-ABCG5 axis in MASH: Editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
by: Yoon-su Ha, et al.
Published: (2025-04-01)

ABCG2 protein expression in tumors of patients with non-resectable pancreatic cancer treated with gemcitabine and nab-paclitaxel
by: Susy Shim, et al.
Published: (2025-06-01)

WNT3 promotes chemoresistance to oxaliplatin in oral squamous cell carcinoma via regulating ABCG2 expression
by: Kairui Sun, et al.
Published: (2025-06-01)

Association of Genetic Polymorphism of ABCG2 Gene and the Occurrence of Oxaliplatin-Induced Peripheral Neuropathy in Patients with Colorectal Cancer
by: Inas M. M. Ahmed, et al.
Published: (2023-12-01)

A key residue of the extracellular gate provides quality control contributing to ABCG substrate specificity
by: Jian Xia, et al.
Published: (2025-05-01)

Bridging the gap: The GOLM1-OPN-ABCG5 axis in MASH and gallstone disease: Editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
by: Nahee Hwang, et al.
Published: (2025-04-01)

The Role of ABCB1, ABCG2, and SLC Transporters in Pharmacokinetic Parameters of Selected Drugs and Their Involvement in Drug–Drug Interactions
by: Kajetan Kiełbowski, et al.
Published: (2024-10-01)

Dichloroacetate enhances Chemo-sensitivity in wild-type P53 breast cancer cells by modulating ABCG2 and NKG2DL
by: Sana Belkahla
Published: (2025-08-01)

Hyperbaric oxygen promotes both the proliferation and chemosensitization of glioblastoma cells by inhibiting HIF1α/HIF2α-ABCG2
by: Sheng Gong, et al.
Published: (2025-04-01)

Polymorphic variants in DOCK7, ABCG8, UBE2E2, and SYN2 genes associated with type 2 diabetes in the Uzbek population
by: Darya Zakirova, et al.
Published: (2025-02-01)

Anthropometric and metabolic differences and distribution of ABCG2 rs2231142 variant between lowland and highland Papuans in West Papua, Indonesia
by: Ferry Fredy Karwur, et al.
Published: (2025-05-01)

Sitosterolemia carrying both ABCG5 and HBA gene mutations: a case report and review of the literature
by: Xiaobing Sun, et al.
Published: (2025-08-01)

Association of the Q141K polymorphism of the ABCG2 gene with the effectiveness of urate-lowering therapy in patients with gout (a pilot study)
by: M. S. Eliseev, et al.
Published: (2021-12-01)

Reply to correspondence 2 on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
by: Nahee Hwang, et al.
Published: (2025-04-01)

Association Between ABCG1/TCF7L2 and Type 2 Diabetes Mellitus: An Intervention Trial Based on a Case–Control Study
by: Yinxia Su, et al.
Published: (2025-01-01)

Differential Expression of Lipid Metabolism Genes, CROT and ABCG1, in Obese Patients with Comorbid Depressive Disorder and Risk of MASLD
by: Joanna Michalina Jurek, et al.
Published: (2025-06-01)

ABCG1 Attenuates Oxidative Stress Induced by H2O2 through the Inhibition of NADPH Oxidase and the Upregulation of Nrf2-Mediated Antioxidant Defense in Endothelial Cells
by: Jiahong Xue, et al.
Published: (2020-01-01)

Dosage of the Abcg1-U2af1 region modifies locomotor and cognitive deficits observed in the Tc1 mouse model of Down syndrome.
by: Damien Marechal, et al.
Published: (2015-01-01)

Effect of ABCG2 c.421 C> A (rs2231142) single nucleotide polymorphisms on the lipid-modulating efficacy of rosuvastatin: a meta-analysis
by: Lingyan Liu, et al.
Published: (2025-03-01)

Hemin Promotes Higher Effectiveness of Aminolevulinic-Photodynamic Therapy (ALA-PDT) in A549 Lung Cancer Cell Line by Interrupting ABCG2 Expression
by: Anantya Pustimbara, et al.
Published: (2024-11-01)

CORRELATION BETWEEN CHEMOTHERAPY RESPONSE AND EXPRESSION PROFILES OF TRANSMEMBRANE PROTEINS: P-GLYCOPROTEIN (ABCB1), MRP2 (ABCC2), BCRP (ABCG2) IN PATIENTS WITH INVASIVE BREAST CANCER
by: К. Yu. Khristenko, et al.
Published: (2016-10-01)

Correspondence to editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
by: Yi-Tong Li, et al.
Published: (2025-04-01)

GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in metabolic dysfunction-associated steatohepatitis livers
by: Yi-Tong Li, et al.
Published: (2025-04-01)

Reply to correspondence 1 on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
by: Yoon-su Ha, et al.
Published: (2025-04-01)

Triglyceride-glucose index and its additive interaction with ABCG2/SLC2A9 polygenic risk score on hyperuricemia in middle age and older adults: findings from the DLCC and BHMC study
by: Huijing He, et al.
Published: (2024-12-01)

Protein expression of cancer stem cell markers ABCG2, podoplanin, and CD44 predicts early recurrence of oral squamous cell carcinoma: A study from Western India
by: Trupti I. Trivedi, et al.
Published: (2025-04-01)

Upregulation of miR-199a/b contributes to cisplatin resistance via Wnt/β-catenin-ABCG2 signaling pathway in ALDHA1 colorectal cancer stem cells
by: Binghe Chen, et al.
Published: (2017-06-01)

MiR-3664-3p through suppressing ABCG2, CYP3A4, MCL1, and MLH1 increases the sensitivity of colorectal cancer cells to irinotecan
by: Elham Farrokhnazar, et al.
Published: (2025-02-01)